dipyridamole has been researched along with Persistent Fetal Circulation Syndrome in 5 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Persistent Fetal Circulation Syndrome: A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Travadi, JN | 1 |
| Patole, SK | 1 |
| Kinsella, JP | 1 |
| Torielli, F | 1 |
| Ziegler, JW | 1 |
| Ivy, DD | 1 |
| Abman, SH | 1 |
| al-Alaiyan, S | 2 |
| al-Omran, A | 1 |
| Dyer, D | 1 |
| Dukarm, RC | 1 |
| Morin, FC | 1 |
| Russell, JA | 1 |
| Steinhorn, RH | 1 |
| Saidy, K | 1 |
1 review available for dipyridamole and Persistent Fetal Circulation Syndrome
| Article | Year |
|---|---|
Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review.
Topics: Dipyridamole; Endothelium-Dependent Relaxing Factors; Humans; Infant, Newborn; Nitric Oxide; Pentoxi | 2003 |
4 other studies available for dipyridamole and Persistent Fetal Circulation Syndrome
| Article | Year |
|---|---|
Dipyridamole augmentation of response to nitric oxide.
Topics: Dipyridamole; Drug Synergism; Hernia, Diaphragmatic; Humans; Infant, Newborn; Nitric Oxide; Persiste | 1995 |
The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide.
Topics: Administration, Inhalation; Blood Gas Analysis; Dipyridamole; Hemodynamics; Humans; Infant, Newborn; | 1996 |
Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension.
Topics: Animals; Animals, Newborn; Cyclic GMP; Dipyridamole; Disease Models, Animal; Female; Hemodynamics; H | 1998 |
The use of L-arginine [correction of F-arginine] and phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide.
Topics: Arginine; Dipyridamole; Female; High-Frequency Ventilation; Humans; Infant, Newborn; Nitric Oxide; P | 2001 |